{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:27Z","timestamp":1791229887217,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":3218,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004342","name":"Wyeth","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004342","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1111\/ajt.12543","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T12:13:30Z","timestamp":1390479210000},"page":"356-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000\u20132003 Phase II Prospective Randomized Trial"],"prefix":"10.1016","volume":"14","author":[{"given":"S.K.","family":"Asrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Klintmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kneteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Teperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Millis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12543_bib1","unstructured":"SRTR. OPTN\/SRTR 2010 Annual Data Report. In: Department of Health, Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation (ed). Rockville, MD, 2011."},{"key":"10.1111\/ajt.12543_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/jlts.2002.35668","article-title":"Chronic renal dysfunction late after liver transplantation","volume":"8","author":"Cohen","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: A retrospective analysis","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12543_bib4","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12543_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12543_bib6","first-page":"CD004290","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients","author":"Webster","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.12543_bib7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/lt.23479","article-title":"Impact of sirolimus and tacrolimus on mortality & graft loss in liver transplant recipients with and without HCV\u2014An analysis of the SRTR database","volume":"18","author":"Watt","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-6143.2011.03919.x","article-title":"Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: A randomized trial","volume":"12","author":"Abdelmalek","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study","volume":"11","author":"Lebranchu","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolate mofetil\/sirolimus maintenance in liver transplantation: The randomized spare-the-nephron trial","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.23835","article-title":"Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis","volume":"52","author":"Asrani","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12543_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/jlts.2003.50079","article-title":"Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications","volume":"9","author":"Dunkelberg","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib13","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1600-6143.2011.03767.x","article-title":"Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression","volume":"11","author":"McKenna","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e318279090c","article-title":"Sirolimus and cardiovascular disease risk in liver transplantation","volume":"95","author":"McKenna","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12543_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jhep.2011.06.013","article-title":"Sirolimus\u2014it doesn\u2019t deserve its bad Rap(a)","volume":"56","author":"McKenna","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12543_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1600-6143.2011.03922.x","article-title":"Sirolimus conversion for renal dysfunction in liver transplant recipients: The devil really is in the details","volume":"12","author":"McKenna","year":"2012","journal-title":"Am J Transplant"},{"issue":"Suppl. 3","key":"10.1111\/ajt.12543_bib17","first-page":"464","article-title":"Sirolimus immunotherapy results in reduced rates of acute rejection in de novo orthotopic liver transplant recipients","volume":"2","author":"Wiesner","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/jlts.2003.50101","article-title":"Rapamycin: Friend, foe, or misunderstood?","volume":"9","author":"Fung","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.transproceed.2012.05.008","article-title":"Biliary complications after orthotopic liver transplantation: A review of incidence and risk factors","volume":"44","author":"Gastaca","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12543_bib20","doi-asserted-by":"crossref","first-page":"913094","DOI":"10.1155\/2011\/913094","article-title":"A decade of experience using mTOR inhibitors in liver transplantation","volume":"2011","author":"Campsen","year":"2011","journal-title":"J Transplant"},{"key":"10.1111\/ajt.12543_bib21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/lt.20845","article-title":"Everolimus and mTOR inhibitors in liver transplantation: Opening the \u201cbox.\u201d","volume":"12","author":"Everson","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12543_bib22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.transproceed.2008.05.068","article-title":"Effects of everolimus monotherapy on hematological parameters and iron homeostasis in de novo liver transplant recipients: Preliminary results","volume":"40","author":"Masetti","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12543_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-2277.2008.00768.x","article-title":"Conversion to everolimus monotherapy in maintenance liver transplantation: Feasibility, safety, and impact on renal function","volume":"22","author":"De Simone","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12543_bib24","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/j.1600-6143.2010.03128.x","article-title":"Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function","volume":"10","author":"Masetti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib25","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib26","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2014PROTECT","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib27","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/ajt.12215","article-title":"Everolimus with reduced tacrolimus in liver transplantation","volume":"13","author":"De Simone","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/ajt.12543_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(99)03882-9","article-title":"Sirolimus\u2013tacrolimus combination immunosuppression","volume":"355","author":"McAlister","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/ajt.12543_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12543_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1432-2277.2009.00969.x","article-title":"Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients","volume":"23","author":"Molinari","year":"2010","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12543_bib32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/ajt.12216","article-title":"Tacrolimus exposure after liver transplantation in randomized controlled trials: Too much for too long","volume":"13","author":"Rodriguez-Peralvarez","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: A randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12543_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: The \u2018ReSpECT\u2019 study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12543","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522253398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522253398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.12543\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:04:16Z","timestamp":1761627856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522253398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1600613522253398"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12543","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000\u20132003 Phase II Prospective Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}